XenoSure is a bovine pericardium patch used primarily for carotid and vascular reconstructions. LeMaitre Vascular, a provider of peripheral vascular devices and implants, will acquire the technology from Neovasc, a developer of vascular surgery tools and products, for $4.6M on Oct. 31.
LeMaitre Vascular has been the exclusive U.S. vascular distributor of XenoSure since January 2009, and owns the XenoSure trademark.
LeMaitre Vascular is headquartered in Burlington, Mass. Neovasc is headquartered in British Columbia, Canada.
Related Articles on Medical Technology:
DePuy Mitek Launches New Rotator Cuff Anchor
Covidien Unveils Cordless Ultrasonic Dissection Device and Stapling System
Abbott Launches Drug Eluting Bioresorbable Vascular Scaffold
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
